Please wait a minute...
文章检索
预防医学  2017, Vol. 29 Issue (11): 1094-1097    DOI: 10.19485/j.cnki.issn1007-0931.2017.11.004
  论著 本期目录 | 过刊浏览 | 高级检索 |
基于GEO芯片数据库的结肠癌易感基因挖掘
钟要红1, 何青芳2, 李迎君1, 丁烨1, 景方圆1, 范春红1
1.杭州医学院,浙江 杭州 310053;
2.浙江省疾病预防控制中心
Mining of susceptible genes of colon cancer based on GEO
Zhong Yao-hong, He Qing-fang, Li Ying-jun, Ding Ye, Jing Fang-yuan, Fan Chun-hong
Hangzhou Medical College,Hangzhou,Zhejiang,310053,China
全文: PDF(497 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 筛选结肠癌的关键基因,探索结肠癌发病机制。方法 从公共基因芯片数据库(GEO)搜索有关结肠癌表达的数据,利用GEO2R筛选表达差异基因,对差异基因进行Gene Ontology(GO)富集分析、信号通路富集分析和蛋白相互作用网络构建。结果 共纳入7套结肠癌基因芯片数据,选出在≥4个数据集中有交集的差异表达基因324个,其中上调基因61个,下调基因263个。324个差异表达基因GO富集分析发现胆汁分泌、药物代谢-细胞色素P450、化学致癌作用等与结肠癌的发病有关。筛选得到骨形态发生蛋白2(BMP2)、CXC趋化因子配体1(CXCL1)、CXCL12、CXCL2、胰高血糖素(GCG)、白细胞介素8(IL8)、基质金属蛋白酶1(MMP1)、蛋白磷酸酶2(PHLPP2)和酪酪肽(PYY) 9个与结肠癌相关的基因。结论 利用生物信息学方法能有效筛选目标基因,并可为进一步研究提供依据。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
钟要红
何青芳
李迎君
丁烨
景方圆
范春红
关键词 结肠癌基因芯片差异表达基因生物信息学    
AbstractObjective To screen the key genes of colon cancer and to explore the pathogenesis of colon cancer. Methods The expression data were searched from Gene Expression Omnibus (GEO) and the differentially expressed genes were selected by GEO2R. The differentially expressed genes were analyzed by gene ontology(GO),KEGG pathway and protein-protein interaction networks. Results A total of 324 differentially expressed genes including 61 upregulated genes and 263 downregulated genes were found in more than three GEO series. An analysis of differentially expressed gene pathways revealed that bile secretion,drug metabolism,cytochrome P450,and chemical carcinogenesis were involved in the pathogenesis of colon cancer. Thus 9 key genes were identified,including BMP2,CXCL1,CXCL12,CXCL2,GCG,IL8,MMP1,PHLPP2 and PYY. Conclusion The key genes could be screened by bioinformatics effectively,which might provide the basis for further experimental study.
Key wordsColon cancer    Microarray    Differentially expressed gene    Bioinformatics
收稿日期: 2017-03-08      修回日期: 2017-06-14     
中图分类号:  R735.35  
基金资助:浙江省公益性技术应用研究(2014C33224)
通信作者: 范春红,E-mail:340076899@qq.com   
作者简介: 钟要红,本科,教授,主要从事营养和流行病学研究工作
引用本文:   
钟要红, 何青芳, 李迎君, 丁烨, 景方圆, 范春红. 基于GEO芯片数据库的结肠癌易感基因挖掘[J]. 预防医学, 2017, 29(11): 1094-1097.
Zhong Yao-hong, He Qing-fang, Li Ying-jun, Ding Ye, Jing Fang-yuan, Fan Chun-hong. Mining of susceptible genes of colon cancer based on GEO. Preventive Medicine, 2017, 29(11): 1094-1097.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn1007-0931.2017.11.004      或      http://www.zjyfyxzz.com/CN/Y2017/V29/I11/1094
[1] CHEN W,ZHENG R,BAADE P D,et al. Cancer statistics in China,2015[J]. CA Cancer J Clin,2016,66(2):115- 132.
[2] JIAO X,SHERMAN B T,HUANG D W,et al. DAVID-WS:a stateful web service to facilitate gene/protein list analysis[J]. Bioinformatics,2012,28(13):1805-1806.
[3] SZKLARCZYK D,FRANCESCHINI A,WYDER S,et al. STRING v10:protein-protein interaction networks,integrated over the tree of life[J]. Nucleic Acids Res,2015,43(Database issue):D447-D452.
[4] RIDLON J M,WOLF P G,GASKINS H R. Taurocholic acid metabolism by gut microbes and colon cancer[J]. Gut Microbes,2016,7(3):201-215.
[5] BEYERLE J,FREI E,STIBOROVA M,et al. Biotransformation of xenobiotics in the human colon and rectum and its association with colorectal cancer[J]. Drug Metab Rev,2015, 47(2):199-221.
[6] VISHNUBLAJI R,YUE S,ALFAYEZ M,et al. Bone morphogenetic protein 2 (BMP2)induces growth suppression and enhances chemosensitivity of human colon cancer cells[J]. Cancer Cell Int,2016(16):77.
[7] VERBEKE H,STRUYF S,LAUREYS G,et al. The expression and role of CXC chemokines in colorectal cancer[J]. Cytokine Growth Factor Rev,2011,22(5-6):345-358.
[8] CAMPBELL J E,DRUCKER D J. Pharmacology,physiology,and mechanisms of incretin hormone action[J]. Cell Metab,2013,17(6):819-837.
[9] DENG L,GUI Z,ZHAO L,et al. Diabetes mellitus and the incidence of colorectal cancer:an updated systematic review and meta-analysis[J]. Dig Dis Sci,2012,57(6):1576-1585.
[10] 徐静权. 罹患结直肠癌的风险与糖尿病的临床相关性分析[D]. 太原:山西医科大学,2016.
[11] JIN W J,XU J M,XU W L,et al. Diagnostic value of interleukin-8 in colorectal cancer:a case-control study and meta-analysis[J]. World J Gastroenterol,2014,20(43):16334-16342.
[12] LIU D,DUAN W,GUO H,et al. Meta-analysis of associations between polymorphisms in the promoter regions of matrix metalloproteinases and the risk of colorectal cancer[J]. Int J Colorectal Dis,2011,26(9):1099-1105.
[13] LI X,STEVENS P D,LIU J,et al. PHLPP is a negative regulator of RAF1,which reduces colorectal cancer cell motility and prevents tumor progression in mice[J]. Gastroenterology,2014,146(5):1301-1312.
[14] PRICE S L,BLOOM S R. Protein PYY and its role in metabolism[J]. Front Horm Res,2014(42):147-154.
[15] ALOSI J A,MCFADDEN D W. Peptide YY mediates inhibition of tumor growth and inflammation[J]. Methods Mol Biol,2009(512):377-394.
[1] 张玉俊, 王岩, 地力亚尔·吾斯曼江, 刘广超, 聂艳武, 朱琳. 应用生物信息学方法鉴定食管鳞状细胞癌生物标志物[J]. 预防医学, 2022, 34(9): 906-913.
[2] 曹彬, 宋燕华. 功能基因组学在苯并[a]芘毒性研究中的应用进展[J]. 预防医学, 2022, 34(2): 151-155,160.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed